Canaccord Genuity analyst maintains Salesforce (NYSE:CRM) with a BuyBy legume / March 7, 2024 / Salesforce Canaccord Genuity analyst David Hynes maintains Salesforce (NYSE:CRM) with a Buy and maintains $350 price target.